COEP News and Press, Coeptis Therapeutics Inc From 05/17/23

2023-05-17 08:59:23 ET Coeptis Therapeutics ( NASDAQ: COEP ) appointed Brian Cogley as CFO, effective immediately. Cogley succeeds Christine Sheehy, who will remain with Coeptis in a senior finance capacity and as vice president of Compliance and Corporate Secretary, the ...

Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer PR Newswire 15-year accounting and finance career spans several sectors including life sciences and underscores financial leadership abilities WEXFORD, Pa. , May 17, 2023 /PRNewswire/ -...

Coeptis Therapeutics' SNAP-CAR Technology Platform for Programmable Antigen Targeting Featured in Peer-Reviewed Article in Nature Communications PR Newswire SNAP-CAR represents a major advance potentially expanding the targeting capabilities of chimeric antigen receptor (CAR) ...

2023-04-19 12:49:23 ET Gainers: SAI.TECH Global Corporation ( SAI ) +48% . Bed Bath & Beyond ( BBBY ) +40% . VYNE Therapeutics ( VYNE ) +34% . Boqii Holding Limited ( BQ ) +30% . CXApp ( CXAI ) +19% . Western Alliance Ban...

2023-04-19 08:21:42 ET Allarity Therapeutics ( ALLR ) -33% . Femasys ( FEMY ) -25% anounces $3.9 million registered direct offering. Oblong ( OBLG ) -21% . Gamida Cell ( GMDA ) -16% on public offering . United Insurance Holdings ( ...

2023-04-18 08:16:25 ET Coeptis Therapeutics ( NASDAQ: COEP ) said it gained an exclusive right, until Aug. 31, to negotiate the acquisition or license certain assets related to Deverra Therapeutics' allogeneic immuno-oncology NK (natural killer) platform. The transaction,...

Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics PR Newswire Proposed transaction would provide Coeptis with two clinical stage assets leveraging NK cell therapies in relapsed or refract...

Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment Strategies PR Newswire Potential acquisition of VyGen-Bio would strengthen Coeptis' oncology pipeline by obtain...

2023-03-27 10:47:00 ET Gainers: Pyxis Oncology ( PYXS ) +25% . Delcath Systems DCTH +23% . Jounce Therapeutics ( JNCE ) +23% . Alimera Sciences ( ALIM ) +22% . Coeptis Therapeutics ( COEP ) +21% . Losers: Unity Biotechnology ...

2023-03-27 08:52:49 ET First Citizens BancShares ( FCNCA ) +39% deal for First Citizens to buy Silicon Valley Bank. First Republic Bank ( FRC ) +24% inks deal for First Citizens to buy Silicon Valley Bank. Baudax  ( BXRX ) +26% Announces Posi...